Capital markets are the backbone of the modern economy, providing the funds that businesses need to invest, grow, and create jobs. Synthetic biology is particularly dependent on capital markets and venture capital investment due to the significant upfront resources needed to launch a synbio startup. But external market conditions can create risks for synbio startups, particularly in later stages. Meanwhile, younger startups need to strongly differentiate themselves to obtain funding and secure their IP. Navigating the investment landscape is a key aspect of starting a synthetic biology company. It’s essential that all synbio entrepreneurs understand the various market paths and nuances of raising capital to grow their businesses.